A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014

Net product sales increased 12.4% to $67.4 million in the first fiscal quarter ended July 26 for Cyberonics, Inc. of Houston, TX. Including license revenue, sales were up 14.2% overall, with Europe in particular contributing a strong performance. Diluted earnings per share were adjusted by $0.17 cents due to a litigation settlement. According to the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014  comments 
formats

Autonomic Technologies’ Sphenopalatine Ganglion Stimulator Treats Cluster Headaches

Autonomic Technologies, Inc. (ATI) is a medical device company located in the San Francisco Bay Area focused on the development of neurostimulators for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache and is currently being investigated in a multi-center, randomized

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Autonomic Technologies’ Sphenopalatine Ganglion Stimulator Treats Cluster Headaches  comments 
formats

Cleveland FES Center’s Networked Neural Prosthesis

The Cleveland FES Center was established in 1991 as a consortium between the Cleveland VA Medical Center (CVAMC), the private educational institution of Case Western Reserve University (CWRU), and the public hospital system of MetroHealth Medical Center (MHMC). As part of this consortium, Dr. Hunter Peckham – biomedical engineering professor at Case Western Reserve University –

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cleveland FES Center’s Networked Neural Prosthesis  comments